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Drug Fever Due to Piperacillin/Tazobactam Loaded into Bone 
Cement
Although drug fever may develop after administration of the drug by various routes, it has 
not been reported with antibiotic-loaded bone cement. Here, a case of drug fever induced 
by piperacillin/tazobactam loaded into bone cement is reported. A 72-yr-old woman 
presented with fever that developed two weeks after insertion of bone cement loaded with 
antibiotics including piperacillin/tazobactam into the knee joint for infectious arthritis. The 
fever was associated with a skin rash and blood eosinophilia. The work-up of the fever 
excluded several causes. Drug provocation test demonstrated that the piperacillin/
tazobactam, which had been loaded in the bone cement, was the cause of the fever. The 
findings of this case suggest that drug fever can be induced by any drug placed and 
released continuously within the body. Therefore, the evaluation for possible drug fever 
should include all drugs the patient has been exposed to regardless of the route of 
administration.
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INTRODUCTION
Drugs have been estimated to cause 10%-15% of adverse reac-
tion in hospitalized patients in the United States (1, 2). Drug fe-
ver occurs in 3%-5% of cases (3). The drug fever is a febrile re-
sponse that coincides temporally with the administration of a 
drug and disappears after discontinuation of the offending agent.
  Prompt recognition of the drug fever is essential. However, 
the drug fever is a common condition that is frequently misdi-
agnosed (1, 3). It is important for clinicians to suspect drugs as 
a cause of fevers of unknown origin (1). Because clinicians tend 
to suspect infection as a cause of a patient’s fever, the drug fever 
can lead to overutilization of antibiotics to treat infections that 
are not present, possibly increasing the risk of adverse drug re-
action and the development of resistance to antibiotics (1). In 
addition, of greater concern is the possibility that the drug fever 
may become more generalized with resultant tissue damage (4).
  The drug fever may develop after administration of the drug 
by various routes. However, to the best of our knowledge, the 
drug fever has not been reported with antibiotic-loaded bone 
cement. Here, a case of drug fever associated with piperacillin/
tazobactam loaded into bone cement, which is confirmed by 
drug provocation test (DPT), is reported.
 
CASE DESCRIPTION
A 72-yr-old woman with a previous history of left total knee re-
placement presented to the department of orthopedics with pain 
and swelling over the left knee joint on May 21, 2009. She under-
went knee joint aspirations in local clinic, and was thought to 
have an infectious knee joint arthritis. She had suffered from 
diabetes mellitus for three years and had no known drug aller-
gy. Surgery was performed to insert bone cement mixed with 
the following antibiotics on May 28, 2009: piperacillin/tazobac-
tam (Tazocin
®, Wyeth Pharm., Seoul, Korea), ceftezol sodium 
(Cetrazol
®, Sam Jin Pharm., Seoul, Korea), gentamicin (Genta-
micin
®, Kuk Je Pharm., Seoul, Korea), and vancomycin hydro-
chloride (Hanomycin
®, Sam Jin Pharm., Seoul, Korea). In addi-
tion, intravenous ceftezol and vancomycin, as well as oral rifam-
picin were administered, as shown in Fig. 1.
  Two weeks after the insertion of the antibiotic-loaded bone 
cement, a fever began to develop. Five days later, a maculopap-
ular skin rash developed (Fig. 1). The blood showed an increased 
eosinophil count (Fig. 1) and C-reactive protein level (11.4 mg/
dL). Initially, a thorough history, physical examination, chest 
radiography, urinalysis, and blood cultures revealed no causes 
of fever. Further work-up to evaluate the fever was performed. 
Serological tests for viral infections, including hepatitis A and B, Park HB, et al.  •  Drug Fever Associated with Antibiotic-loaded Bone Cement
302   http://jkms.org DOI: 10.3346/jkms.2011.26.2.301
Epstein-Barr virus, human immunodeficiency virus, and cyto-
megalovirus, were all negative. Auto-antibody screening tests 
were negative for antinuclear and anti-neutrophil-cytoplasmic 
antibodies. The total immunoglobulin E level was 361 IU/mL. 
The C3 and C4 levels were within normal range; however, the 
CH50 had decreased to 17 U/mL. Trans-thoracic echocardiog-
raphy, computed tomography of the abdomen and chest, and 
sigmoidoscopy showed no abnormal findings. The etiology of 
the fever was unknown. Finally, the possibility of a drug fever 
was considered. Since then, no systemic antibiotics had been 
administered. However, the fever persisted for two weeks. Body 
temperature returned to normal one month after the insertion 
of bone cement (Fig. 1).
  The skin prick tests, intradermal tests, and patch tests were 
negative for the drugs: piperacillin/tazobactam, ceftezol sodi-
um, gentamicin, vancomycin and rifampicin. A single blind DPT 
was performed with a single administration of therapeutic dose 
for each drug after written informed consent was obtained. DPTs 
for ceftezol, gentamicin and rifampicin were negative. However, 
the DPT for piperacillin/tazobactam was positive; body temper-
ature increased two hours after intravenous administration of 
piperacillin/tazobactam 2.25 g, and gradually decreased to nor-
mal within 72 hr (Fig. 2). No skin rash was accompanied. The 
DPT to vancomycin showed a reaction consistent with the red 
man syndrome; however, no reactions were observed during a 
five hour-slow infusion. Since then, vancomycin has been used 
with a slow infusion without any adverse reactions for the in-
fectious arthritis.
  Finally, our case was confirmed as having drug fever due to 
piperacillin/tazobactam loaded into bone cement, which was 
inserted into the knee joint for the infectious arthritis. The pa-
tient was recommended to avoid the use the offending antibi-
otic.
DISCUSSION
In the present case, fever developed two weeks after the inser-
tion of bone cement loaded with antibiotics including piperacil-
lin/tazobactam into the knee joint. The fever was associated with 
a skin rash and blood eosinophilia. The work-up of the fever ex-
cluded several causes. The DPT demonstrated that the piper-
acillin/tazobactam, which had been loaded in the bone cement, 
was the cause of the fever. Finally, the present case was diagnosed 
with drug fever induced by piperacillin/tazobactam loaded into 
bone cement.
  The onset of drug fever is highly variable and differs among 
drug classes, but most commonly appears after one to two weeks 
of drug administration (5). Bone cement mixed with antibiotics 
has been developed to treat local infections of the bone and soft 
tissue (6). A sustained level of the antibiotic is released to the 
systemic circulation from the bone cement (7, 8). The bone ce-
ment may be assumed to release piperacillin/tazobactam to the 
Fig. 2. Drug provocation test with piperacillin/tazobactam.
T
e
m
p
e
r
a
t
u
r
e
 
(
°
C
)
39.0
38.5
38.0
37.5
37.0
36.5
36.0
35.5
Time (hr)
-28 -20   -16 -4  0  2  4  8  12 14 17 20 24 28 32 36 38 41 44 48 52 56 60 68 72
Drug  
provocation
T
e
m
p
e
r
a
t
u
r
e
 
(
°
C
)
B
l
o
o
d
 
e
o
s
i
n
o
p
h
i
l
 
c
o
u
n
t
 
(
c
e
l
l
s
/
µ
L
)
Days after the insertion of bone cement
Temperature
Eosinophil Ceftezol
Insertion of 
antibiotic-loaded 
bone cement
Rash
Vancomycin 
Rifampicin
  0  2  4  6  8  10  12  14  16  18  20  22  24  26  28  30  32  34
40.0
39.5
39.0
38.5
38.0
37.5
37.0
36.5
36.0
800
600
400
200
0
Fig. 1. The development of fever, skin rash and blood eosinophilia in relation to the insertion of antibiotic-loaded bone cement and the administration of systemic antibiotics. The 
bone cement was loaded with piperacillin/tazobactam, ceftezol sodium, gentamicin and vancomycin hydrochloride.Park HB, et al.  •  Drug Fever Associated with Antibiotic-loaded Bone Cement
http://jkms.org   303 DOI: 10.3346/jkms.2011.26.2.301
systemic circulation at least for two weeks in the present case, 
based on the observation that the drug fever developed two 
weeks after the insertion of antibiotic-loaded bone cement. The 
piperacillin/tazobactam is expected to be continuously released 
until one month after the insertion of bone cement, on the basis 
of the finding that the fever disappeared one month after the 
insertion (Fig. 1). The drug fever usually disappears within 48 to 
72 hr after withdrawal of the offending agent (4). Kelm et al. (9) 
showed that antibiotic-impregnated polymethylmethacrylate 
hip spacers could inhibit bacterial growth in vitro for 14 to 30 
days, suggesting that the antibiotic can be released for at least 
two weeks.
  Our case had evidences to support the diagnosis of drug fever. 
In drug fever, readministration of the drug produces fever with-
in a matter of hours (4). In the present case, DPT revealed a typ-
ical response of drug fever to piperacillin/tazobactam. Fever 
developed two hours after intravenous administration of piper-
acillin/tazobactam and gradually decreased to normal within 
72 hours. Drug fever is commonly associated with skin rash and 
blood eosinophilia (4), which were also observed in the present 
case. The diagnosis of drug fever is one of exclusion after elimi-
nating other potential causes of the febrile reaction; other causes 
were excluded in the present case. Furthermore, piperacillin is 
a well known antimicrobial associated with drug fever (5). In 
the present case, DPT was performed with a single administra-
tion of therapeutic dose. However, it may be safer that DPT is 
performed with graded challenge, which is to administer suffi-
ciently small doses that would not cause a serious reaction ini-
tially, and to increase the dose by safe increments (usually 2- 
fold to 10-fold) over a matter of hours or days until a therapeutic 
dose is achieved. Generally, the initial starting dose is 1% of the 
therapeutic dose (4).
  The mechanisms associated with drug fever are suggested to 
be mediated by the formation of circulating antibody-antigen 
complexes or T-cell lymphocyte immune responses (5). Based 
on the low serum CH50 levels, the formation of immune com-
plexes with the activation of complement may have been partly 
involved in the development of the drug fever in the present case.
  In conclusion, the findings of this case suggest that drug fever 
can be induced by any drug placed and released continuously 
within the body. Therefore, the evaluation for possible drug fe-
ver should include all drugs the patient has been exposed to re-
gardless of the route of administration.
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